Kyl, McCain’s Chosen Replacement, Lobbied Against Drug-Price Measures McCain Backed

September 05, 2018

Jon Kyl, the former Arizona senator chosen to serve out the term of the late Sen. John McCain (R), lobbied for the brand drug industry since 2015, according to lobbyist filings for Kyl’s firm, Covington & Burling. Although McCain advocated for drug imports and against the brand drug industry practice of using post-market drug safety plans to block generic competition, Kly lobbied on the other side of those policies. Arizona Gov. Doug Ducey said Tuesday (Sept. 4) at a press...

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

Login

Kyl, McCain’s Chosen Replacement, Lobbied Against Drug-Price Measures McCain Backed

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.